<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc" /><meta name="ncbi_pdid" content="article" /><meta name="ncbi_acc" content="" /><meta name="ncbi_domain" content="bmcmedgeno" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/articles/PMC4640351/" /><meta name="ncbi_app" content="pmc" />
        <!-- Logger end -->
        
        <title>MiRNA profiling of whole trabecular bone: identification of osteoporosis-related changes in MiRNAs in human hip bones</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640351/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="BMC Medical Genomics" /><meta name="citation_title" content="MiRNA profiling of whole trabecular bone: identification of osteoporosis-related changes in MiRNAs in human hip bones" /><meta name="citation_authors" content="Laura De-Ugarte, Guy Yoskovitz, Susana Balcells, Robert Güerri-Fernández, Santos Martinez-Diaz, Leonardo Mellibovsky, Roser Urreizti, Xavier Nogués, Daniel Grinberg, Natalia García-Giralt, Adolfo Díez-Pérez" /><meta name="citation_date" content="2015" /><meta name="citation_volume" content="8" /><meta name="citation_doi" content="10.1186/s12920-015-0149-2" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC4640351/?report=abstract" /><meta name="citation_pmid" content="26555194" /><meta name="DC.Title" content="MiRNA profiling of whole trabecular bone: identification of osteoporosis-related changes in MiRNAs in human hip bones" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="BioMed Central" /><meta name="DC.Contributor" content="Laura De-Ugarte" /><meta name="DC.Contributor" content="Guy Yoskovitz" /><meta name="DC.Contributor" content="Susana Balcells" /><meta name="DC.Contributor" content="Robert Güerri-Fernández" /><meta name="DC.Contributor" content="Santos Martinez-Diaz" /><meta name="DC.Contributor" content="Leonardo Mellibovsky" /><meta name="DC.Contributor" content="Roser Urreizti" /><meta name="DC.Contributor" content="Xavier Nogués" /><meta name="DC.Contributor" content="Daniel Grinberg" /><meta name="DC.Contributor" content="Natalia García-Giralt" /><meta name="DC.Contributor" content="Adolfo Díez-Pérez" /><meta name="DC.Date" content="2015" /><meta name="DC.Identifier" content="10.1186/s12920-015-0149-2" /><meta name="DC.Language" content="en" /><meta property="og:title" content="MiRNA profiling of whole trabecular bone: identification of osteoporosis-related changes in MiRNAs in human hip bones" /><meta property="og:type" content="article" /><meta property="og:description" content="MicroRNAs (miRNAs) are important regulators of gene expression, with documented roles in bone metabolism and osteoporosis, suggesting potential therapeutic targets. Our aim was to identify miRNAs differentially expressed in fractured vs nonfractured bones. ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640351/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbi" /><link rel="stylesheet" href="/corehtml/pmc/css/3.9.1/pmc.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.9.1/pmc_extras_prnt.min.css" type="text/css" media="print" /><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:'/pmc/utils/ctxp/'" /><script type="text/javascript" src="/corehtml/pmc/ctxp/jquery.citationexporter.js">//</script><link rel="stylesheet" href="/corehtml/pmc/ctxp/citationexporter.css" type="text/css" /><script type="text/javascript" src="/core/mathjax/2.6.1/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-bmcmedgeno.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><meta name="cited_in_systematic_reviews" content="" /><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC4640351/epub/" /><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC4640351/pdf/12920_2015_Article_149.pdf" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="F4FC6075B4D23A2100000000008E006F.m_8" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print" /></head>
    <body class="article">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo">
  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br />
    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="clone">Clone</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="nucest">EST</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="nucgss">GSS</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="pubmedhealth">PubMed Health</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option><option value="unigene">UniGene</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="archive"><a class="navlink" href="/pmc/journals/573/">BMC Med Genomics</a></li><li class="issue-page"><a class="navlink" href="/pmc/issues/248132/">v.8; 2015</a></li><li class="accid">PMC4640351</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-bmcmedgeno.png" alt="Logo of bmcmedgeno" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,0,162,75" alt="BioMed Central" title="BioMed Central" href="http://www.biomedcentral.com/" ref="reftype=publisher&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A&amp;rendering-type=normal" target="pmc_ext" /><area shape="rect" coords="247,59,296,75" alt="search" title="search" href="http://www.biomedcentral.com/bmcmedgenomics/search" ref="reftype=publisher&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A&amp;rendering-type=normal" target="pmc_ext" /><area shape="rect" coords="301,59,405,75" alt="submit a manuscript" title="submit a manuscript" href="http://www.biomedcentral.com/bmcmedgenomics/manuscript" ref="reftype=publisher&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A&amp;rendering-type=normal" target="pmc_ext" /><area shape="rect" coords="415,59,458,75" alt="register" title="register" href="http://www.biomedcentral.com/bmcmedgenomics/register" ref="reftype=publisher&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A&amp;rendering-type=normal" target="pmc_ext" /><area shape="rect" coords="185,59,244,75" alt="this article" title="this article" href="//dx.doi.org/10.1186/s12920-015-0149-2" ref="reftype=publisher&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CBanner&amp;TO=Content%20Provider%7CArticle%7CFullText&amp;rendering-type=normal" target="pmc_ext" /><area shape="rect" coords="0,0,480,75" alt="BMC Medical Genomics" title="BMC Medical Genomics" href="http://www.biomedcentral.com/bmcmedgenomics" ref="reftype=publisher&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A&amp;rendering-type=normal" target="pmc_ext" /></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="small"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span id="pmcmata">BMC Med Genomics</span>. 2015; 8: 75. </span></div><div><span class="fm-vol-iss-date">Published online 2015 Nov 10. </span>  <span class="doi">doi:  <a href="//dx.doi.org/10.1186%2Fs12920-015-0149-2" target="pmc_ext" ref="reftype=other&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">10.1186/s12920-015-0149-2</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC4640351</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/26555194">26555194</a></div></div></div></div></div><h1 class="content-title">MiRNA profiling of whole trabecular bone: identification of osteoporosis-related changes in MiRNAs in human hip bones</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=De-Ugarte%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26555194" class="affpopup" co-rid="_co_idm139797522753200" co-class="co-affbox">Laura De-Ugarte</a>,<sup></sup> <a href="/pubmed/?term=Yoskovitz%20G%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26555194" class="affpopup" co-rid="_co_idm139797518974544" co-class="co-affbox">Guy Yoskovitz</a>,<sup></sup> <a href="/pubmed/?term=Balcells%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26555194" class="affpopup" co-rid="_co_idm139797518533024" co-class="co-affbox">Susana Balcells</a>,<sup></sup> <a href="/pubmed/?term=G%26%23x000fc%3Berri-Fern%26%23x000e1%3Bndez%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26555194" class="affpopup" co-rid="_co_idm139797512754368" co-class="co-affbox">Robert G&#x000fc;erri-Fern&#x000e1;ndez</a>,<sup></sup><sup></sup> <a href="/pubmed/?term=Martinez-Diaz%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26555194" class="affpopup" co-rid="_co_idm139797520104064" co-class="co-affbox">Santos Martinez-Diaz</a>,<sup></sup> <a href="/pubmed/?term=Mellibovsky%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26555194" class="affpopup" co-rid="_co_idm139797520101680" co-class="co-affbox">Leonardo Mellibovsky</a>,<sup></sup><sup></sup> <a href="/pubmed/?term=Urreizti%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26555194" class="affpopup" co-rid="_co_idm139797521770944" co-class="co-affbox">Roser Urreizti</a>,<sup></sup> <a href="/pubmed/?term=Nogu%26%23x000e9%3Bs%20X%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26555194" class="affpopup" co-rid="_co_idm139797517595168" co-class="co-affbox">Xavier Nogu&#x000e9;s</a>,<sup></sup><sup></sup> <a href="/pubmed/?term=Grinberg%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26555194" class="affpopup" co-rid="_co_idm139797517583184" co-class="co-affbox">Daniel Grinberg</a>,<sup></sup> <a href="/pubmed/?term=Garc%26%23x000ed%3Ba-Giralt%20N%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26555194" class="affpopup" co-rid="_co_idm139797525123488" co-class="co-affbox">Natalia Garc&#x000ed;a-Giralt</a>,<sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup></sup> and  <a href="/pubmed/?term=D%26%23x000ed%3Bez-P%26%23x000e9%3Brez%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26555194" class="affpopup" co-rid="_co_idm139797526803088" co-class="co-affbox">Adolfo D&#x000ed;ez-P&#x000e9;rez</a><sup></sup><sup></sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm139797522753200"><h3 class="no_margin">Laura De-Ugarte</h3><p><sup></sup>Musculoskeletal research group, IMIM (Hospital del Mar Medical Research Institute), Red Tem&#x000e1;tica de Investigaci&#x000f3;n Cooperativa en Envejecimiento y Fragilidad (RETICEF), ISCIII, Barcelona, Spain </p><div>Find articles by <a href="/pubmed/?term=De-Ugarte%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26555194">Laura De-Ugarte</a></div></div><div id="_co_idm139797518974544"><h3 class="no_margin">Guy Yoskovitz</h3><p><sup></sup>Musculoskeletal research group, IMIM (Hospital del Mar Medical Research Institute), Red Tem&#x000e1;tica de Investigaci&#x000f3;n Cooperativa en Envejecimiento y Fragilidad (RETICEF), ISCIII, Barcelona, Spain </p><div>Find articles by <a href="/pubmed/?term=Yoskovitz%20G%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26555194">Guy Yoskovitz</a></div></div><div id="_co_idm139797518533024"><h3 class="no_margin">Susana Balcells</h3><p><sup></sup>Departament de Gen&#x000e8;tica, Centro de Investigaci&#x000f3;n Biom&#x000e9;dica en Red de Enfermedades Raras (CIBERER), ISCIII, Universitat de Barcelona, IBUB, Barcelona, Spain </p><div>Find articles by <a href="/pubmed/?term=Balcells%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26555194">Susana Balcells</a></div></div><div id="_co_idm139797512754368"><h3 class="no_margin">Robert G&#x000fc;erri-Fern&#x000e1;ndez</h3><p><sup></sup>Musculoskeletal research group, IMIM (Hospital del Mar Medical Research Institute), Red Tem&#x000e1;tica de Investigaci&#x000f3;n Cooperativa en Envejecimiento y Fragilidad (RETICEF), ISCIII, Barcelona, Spain </p><p><sup></sup>Internal Medicine Department, Hospital del Mar, Universitat Aut&#x000f2;noma de Barcelona, Barcelona, Spain </p><div>Find articles by <a href="/pubmed/?term=G%26%23x000fc%3Berri-Fern%26%23x000e1%3Bndez%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26555194">Robert G&#x000fc;erri-Fern&#x000e1;ndez</a></div></div><div id="_co_idm139797520104064"><h3 class="no_margin">Santos Martinez-Diaz</h3><p><sup></sup>Orthopaedic Surgery and Traumatology Department, Hospital del Mar, Universitat Aut&#x000f2;noma de Barcelona, Barcelona, Spain </p><div>Find articles by <a href="/pubmed/?term=Martinez-Diaz%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26555194">Santos Martinez-Diaz</a></div></div><div id="_co_idm139797520101680"><h3 class="no_margin">Leonardo Mellibovsky</h3><p><sup></sup>Musculoskeletal research group, IMIM (Hospital del Mar Medical Research Institute), Red Tem&#x000e1;tica de Investigaci&#x000f3;n Cooperativa en Envejecimiento y Fragilidad (RETICEF), ISCIII, Barcelona, Spain </p><p><sup></sup>Internal Medicine Department, Hospital del Mar, Universitat Aut&#x000f2;noma de Barcelona, Barcelona, Spain </p><div>Find articles by <a href="/pubmed/?term=Mellibovsky%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26555194">Leonardo Mellibovsky</a></div></div><div id="_co_idm139797521770944"><h3 class="no_margin">Roser Urreizti</h3><p><sup></sup>Departament de Gen&#x000e8;tica, Centro de Investigaci&#x000f3;n Biom&#x000e9;dica en Red de Enfermedades Raras (CIBERER), ISCIII, Universitat de Barcelona, IBUB, Barcelona, Spain </p><div>Find articles by <a href="/pubmed/?term=Urreizti%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26555194">Roser Urreizti</a></div></div><div id="_co_idm139797517595168"><h3 class="no_margin">Xavier Nogu&#x000e9;s</h3><p><sup></sup>Musculoskeletal research group, IMIM (Hospital del Mar Medical Research Institute), Red Tem&#x000e1;tica de Investigaci&#x000f3;n Cooperativa en Envejecimiento y Fragilidad (RETICEF), ISCIII, Barcelona, Spain </p><p><sup></sup>Internal Medicine Department, Hospital del Mar, Universitat Aut&#x000f2;noma de Barcelona, Barcelona, Spain </p><div>Find articles by <a href="/pubmed/?term=Nogu%26%23x000e9%3Bs%20X%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26555194">Xavier Nogu&#x000e9;s</a></div></div><div id="_co_idm139797517583184"><h3 class="no_margin">Daniel Grinberg</h3><p><sup></sup>Departament de Gen&#x000e8;tica, Centro de Investigaci&#x000f3;n Biom&#x000e9;dica en Red de Enfermedades Raras (CIBERER), ISCIII, Universitat de Barcelona, IBUB, Barcelona, Spain </p><div>Find articles by <a href="/pubmed/?term=Grinberg%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26555194">Daniel Grinberg</a></div></div><div id="_co_idm139797525123488"><h3 class="no_margin">Natalia Garc&#x000ed;a-Giralt</h3><p><sup></sup>Musculoskeletal research group, IMIM (Hospital del Mar Medical Research Institute), Red Tem&#x000e1;tica de Investigaci&#x000f3;n Cooperativa en Envejecimiento y Fragilidad (RETICEF), ISCIII, Barcelona, Spain </p><div>Find articles by <a href="/pubmed/?term=Garc%26%23x000ed%3Ba-Giralt%20N%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26555194">Natalia Garc&#x000ed;a-Giralt</a></div></div><div id="_co_idm139797526803088"><h3 class="no_margin">Adolfo D&#x000ed;ez-P&#x000e9;rez</h3><p><sup></sup>Musculoskeletal research group, IMIM (Hospital del Mar Medical Research Institute), Red Tem&#x000e1;tica de Investigaci&#x000f3;n Cooperativa en Envejecimiento y Fragilidad (RETICEF), ISCIII, Barcelona, Spain </p><p><sup></sup>Internal Medicine Department, Hospital del Mar, Universitat Aut&#x000f2;noma de Barcelona, Barcelona, Spain </p><div>Find articles by <a href="/pubmed/?term=D%26%23x000ed%3Bez-P%26%23x000e9%3Brez%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=26555194">Adolfo D&#x000ed;ez-P&#x000e9;rez</a></div></div></div></div><div class="fm-panel small half_rhythm"><div class="fm-authors-info fm-panel hide half_rhythm" id="idm139797595297632_ai" style="display:none"><div class="fm-affl" lang="en" id="Aff1"><sup></sup>Musculoskeletal research group, IMIM (Hospital del Mar Medical Research Institute), Red Tem&#x000e1;tica de Investigaci&#x000f3;n Cooperativa en Envejecimiento y Fragilidad (RETICEF), ISCIII, Barcelona, Spain </div><div class="fm-affl" lang="en" id="Aff2"><sup></sup>Departament de Gen&#x000e8;tica, Centro de Investigaci&#x000f3;n Biom&#x000e9;dica en Red de Enfermedades Raras (CIBERER), ISCIII, Universitat de Barcelona, IBUB, Barcelona, Spain </div><div class="fm-affl" lang="en" id="Aff3"><sup></sup>Internal Medicine Department, Hospital del Mar, Universitat Aut&#x000f2;noma de Barcelona, Barcelona, Spain </div><div class="fm-affl" lang="en" id="Aff4"><sup></sup>Orthopaedic Surgery and Traumatology Department, Hospital del Mar, Universitat Aut&#x000f2;noma de Barcelona, Barcelona, Spain </div><div><span class="fm-affl">Laura De-Ugarte, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="se.mimi@etraguedl" class="oemail">se.mimi@etraguedl</a></span>.</div><div><a href="#idm139797595297632aff-info">Contributor Information</a>.</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup>Corresponding author.</div></div><div class="togglers"><a href="#" class="pmctoggle" rid="idm139797595297632_ai">Author information <span>►</span></a> <a href="#" class="pmctoggle" rid="idm139797595297632_an">Article notes <span>►</span></a> <a href="#" class="pmctoggle" rid="idm139797595297632_cpl">Copyright and License information <span>►</span></a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm139797595297632_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2015 Mar 5; Accepted 2015 Oct 30.</div></div><div class="fm-cpl-info fm-panel hide half_rhythm" id="idm139797595297632_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; De-Ugarte et al. 2015</div><div class="fm-copyright half_rhythm"><div class="license">
<strong>Open Access</strong>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<a href="http://creativecommons.org/licenses/by/4.0/" ref="reftype=extlink&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">http://creativecommons.org/licenses/by/4.0/</a>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<a href="http://creativecommons.org/publicdomain/zero/1.0/" ref="reftype=extlink&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">http://creativecommons.org/publicdomain/zero/1.0/</a>) applies to the data made available in this article, unless otherwise stated.</div></div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="small"><div><strong>This article has been corrected. </strong>See <a href="/pmc/articles/PMC5442687/">BMC Med Genomics. 2017 May 23; 10: 36</a>.</div><div style="border-top: 1px solid rgb(102, 102, 153); margin: 5px 10% 3px;"></div><div>This article has been <a href="/pmc/articles/PMC4640351/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="Abs1" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="Abs1title">Abstract</h2><!--article-meta--><div><div id="__sec1" class="sec sec-first"><h2>Background</h2><p id="__p1" class="p p-first-last">MicroRNAs (miRNAs) are important regulators of gene expression, with documented roles in bone metabolism and osteoporosis, suggesting potential therapeutic targets. Our aim was to identify miRNAs differentially expressed in fractured vs nonfractured bones. Additionally, we performed a miRNA profiling of primary osteoblasts to assess the origin of these differentially expressed miRNAs.</p></div><div id="__sec2" class="sec"><h2>Methods</h2><p id="__p2" class="p p-first-last">Total RNA was extracted from (a) fresh femoral neck trabecular bone from women undergoing hip replacement due to either osteoporotic fracture (OP group, <em>n</em>&#x02009;=&#x02009;6) or osteoarthritis in the absence of osteoporosis (Control group, <em>n</em>&#x02009;=&#x02009;6), matching the two groups by age and body mass index, and (b) primary osteoblasts obtained from knee replacement due to osteoarthritis (<em>n</em>&#x02009;=&#x02009;4). Samples were hybridized to a microRNA array containing more than 1900 miRNAs. Principal component analysis (PCA) plots and heat map hierarchical clustering were performed. For comparison of expression levels, the threshold was set at log fold change&#x02009;&#x0003e;&#x02009;1.5 and a p-value&#x02009;&#x0003c;&#x02009;0.05 (corrected for multiple testing).</p></div><div id="__sec3" class="sec"><h2>Results</h2><p id="__p3" class="p p-first">Both PCA and heat map analyses showed that the samples clustered according to the presence or absence of fracture. Overall, 790 and 315 different miRNAs were detected in fresh bone samples and in primary osteoblasts, respectively, 293 of which were common to both groups. A subset of 82 miRNAs was differentially expressed (<em>p</em>&#x02009;&#x0003c;&#x02009;0.05) between osteoporotic and control osteoarthritic samples.</p><p id="__p4" class="p p-last">The eight miRNAs with the lowest p-values (and for which a validated miRNA qPCR assay was available) were assayed, and two were confirmed: miR-320a and miR-483-5p. Both were over-expressed in the osteoporotic samples and expressed in primary osteoblasts. miR-320a is known to target <em>CTNNB1</em> and predicted to regulate <em>RUNX2 and LEPR,</em> while miR-483-5p down-regulates IGF2. We observed a reduction trend for this target gene in the osteoporotic bone.</p></div><div id="__sec4" class="sec"><h2>Conclusions</h2><p id="__p5" class="p p-first-last">We identified two osteoblast miRNAs over-expressed in osteoporotic fractures, which opens novel prospects for research and therapy.</p></div><div id="__sec5" class="sec sec-last"><h2>Electronic supplementary material</h2><p id="__p6" class="p p-first-last">The online version of this article (doi:10.1186/s12920-015-0149-2) contains supplementary material, which is available to authorized users.</p></div></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">Osteoporosis, microRNAs, Osteoblast, Fracture, Epigenetic regulation</span></div></div><div id="Sec1" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec1title">Background</h2><p id="__p7" class="p p-first">Increasing evidence indicates that epigenetic mechanisms are fundamental to the regulation of gene expression. Among them, microRNAs (miRNAs) are small (18&#x02013;24&#x000a0;nt), non-coding RNAs that negatively regulate gene expression post-transcriptionally by binding to 3&#x02019;-UTRs of target mRNAs. Deregulation of any of the processes with which miRNAs have been associated &#x02013;including proliferation, differentiation, and apoptosis-could induce pathophysiological conditions, some of them severe, such as cancer [<a href="#CR1" rid="CR1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_486786969">1</a>].</p><p id="__p8">In bone, miRNAs have been described as key factors regulating bone formation, remodelling, and homeostasis [<a href="#CR2" rid="CR2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_486786960">2</a>, <a href="#CR3" rid="CR3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_486786987">3</a>]. Several studies have shown that miRNAs are involved in the control of bone cell differentiation and function, as well as lineage commitment and cell progression of mesenchymal stem cells [<a href="#CR4" rid="CR4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_486786962">4</a>]. The understanding of miRNA regulation pathways and the identification of miRNAs involved in skeletal function will be essential to the development of miRNA-based therapeutic strategies for bone diseases. In the field of osteoporosis pathophysiology, very few reports on defects in miRNAs regulation mechanisms are available to date. Li et al. [<a href="#CR5" rid="CR5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_486786986">5</a>] described a mutation in pre-miR-2861 that blocked expression of miR-2861 and caused primary osteoporosis in two related adolescents. In another study, three polymorphisms in the 3&#x02019;UTR of the <em>FGF2</em> gene were genetically associated with bone mineral density (BMD) of the femoral neck [<a href="#CR6" rid="CR6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_486786963">6</a>]. These genetic variants were located in target sequences for miR-146a and miR-146b.</p><p id="__p9">Very recently, Seeliger et al. [<a href="#CR7" rid="CR7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_486786970">7</a>] and Garmilla-Ezquerra et al. [<a href="#CR8" rid="CR8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_486786974">8</a>] performed a microRNA analysis from total bone tissue comparing osteoporotic vs non-osteoporotic bone. Seeliger et al. [<a href="#CR7" rid="CR7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_486786975">7</a>] have identified 6 miRNAs upregulated in osteoporotic fracture patients: miR-21, miR-23a, miR-24, miR-25, miR-100 and miR-125b meanwhile Garmilla-Ezquerra et al. [<a href="#CR8" rid="CR8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_486786981">8</a>] detected miR-187 and miR-518f as differentially expressed between sample groups. Remarkably, both studies detected different miRNAs involved in the osteoporotic physiopathology.</p><p id="__p10">One handicap in the study of miRNAs is their highly variable expression, which depends on cell status (differentiation, proliferation) as well as environment (hormones, cytokines, and other signalling factors). Indeed, profiling miRNA expression in different cell sources of osteoblastic lineage or under different treatments or pathological status results in a variety of bone-regulatory miRNA subsets [<a href="#CR9" rid="CR9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_486786973">9</a>, <a href="#CR10" rid="CR10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_486786976">10</a>]. Moreover, studies using cells from diverse mammalian species or established cell lines and different culture conditions can identify different miRNAs, making it difficult to compare experiments and results and/or to extrapolate to in vivo physiological conditions.</p><p id="__p11">The aim of this study was to identify miRNAs with altered expression in osteoporotic bone, using an experimental methodology that mimics the physiological conditions. For this purpose, fresh trabecular bone samples from patients with osteoporosis and a recent fracture were compared to those of non-osteoporotic individuals. MicroRNA array analysis was performed in total bone tissue to detect all miRNAs expressed in these samples. Unlike the previous two mentioned reports [<a href="#CR7" rid="CR7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_486786985">7</a>, <a href="#CR8" rid="CR8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_486786959">8</a>], extremely care was taken in sample selection, resulting in homogenous anthropometric parameters such as age, body mass index (BMI) and gender between groups. Moreover, patients with disorders affecting bone remodelling were excluded from the study.</p><p id="__p12" class="p p-last">Furthermore, a complementary array was made from human primary osteoblasts in order to assess which miRNAs from the total bone array were expressed in osteoblastic cells.</p></div><div id="Sec2" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec2title">Methods</h2><div id="Sec3" class="sec sec-first"><h3>Ethics statement</h3><p id="__p13" class="p p-first-last">The Clinical Research Ethics Committee of Parc de Salut MAR approved the present research. The approved protocols for obtaining fresh bone (and primary osteoblasts) from hip or knee samples otherwise discarded at the time of orthopaedic surgery were explained to potential study participants, who provided written informed consent before being included in the study.</p></div><div id="Sec4" class="sec"><h3>Bone samples and RNA extraction</h3><p id="__p14" class="p p-first">In order to perform the microarray, fresh femoral neck trabecular bone was obtained from 12 postmenopausal women (discovery samples) undergoing hip replacement due to either osteoporotic fracture (<em>n</em>&#x02009;=&#x02009;6) or osteoarthritis in the absence of osteoporosis (<em>n</em>&#x02009;=&#x02009;6) (according to BMD and T-score measurements [mean&#x02009;&#x000b1;&#x02009;SD]: 0.794&#x02009;&#x000b1;&#x02009;0.074 and &#x02212;0.25&#x02009;&#x000b1;&#x02009;0.827, respectively). For the replication stage, a new set of samples were collected: 7 postmenopausal women with osteoporotic fracture and 6 with osteoarthritis in the absence of osteoporosis (according to BMD and T-score measurements [mean&#x02009;&#x000b1;&#x02009;SD]: 0.882&#x02009;&#x000b1;&#x02009;0.158 and - 0.342&#x02009;&#x000b1;&#x02009;1.622, respectively). The osteoarthritic samples were considered the control group because the BMD values classified them as non-osteoporotic. None of the participants had a history of metabolic or endocrine disease, chronic renal failure, chronic liver disease, malignancy, Paget&#x02019;s disease of bone, malabsorption syndrome, hormone replacement therapy, anti-resorptive or anabolic agents, oral corticosteroids, anti-epileptic drugs, or treatment with lithium, heparin, or warfarin.</p><p id="__p15" class="p p-last">Bony fragments were extracted from the transcervical region of the femoral neck for both osteoporotic fracture (OP) and control samples. Total fresh bone samples were cut into small fragments, triple washed in phosphate buffered solution (PBS), and stored at &#x02212;80&#x000a0;&#x000b0;C until use. RNA extraction was performed at TATAA Biocenter in Gothenburg, Sweden. A piece of tissue was cut out and used in the extraction, following the manufacturer&#x02019;s instructions for the miRNeasy Mini kit (Qiagen). QIAzol Lysis Reagent was added to the samples and homogenized for 5&#x000a0;min using the TissueLyser system. Chloroform was added to each sample, followed by centrifugation for 15&#x000a0;min at 12000&#x000a0;g. The upper water phase was collected and the extraction continued according to manufacturer&#x02019;s instructions. The concentration of the purified RNA was analysed on a spectrophotometer (Nanodrop, Thermo Fisher Scientific Inc).</p></div><div id="Sec5" class="sec"><h3>Human osteoblast culture</h3><p id="__p16" class="p p-first-last">Human primary osteoblasts (hOB) were obtained from trabecular bone of postmenopausal women after knee replacement due to osteoarthritis (<em>n</em>&#x02009;=&#x02009;4). Mean age (&#x000b1; SD) was 71.50&#x02009;&#x000b1;&#x02009;9.95&#x000a0;years and BMI was 30.44&#x02009;&#x000b1;&#x02009;2.43. Bony tissue was cut into small pieces, washed in PBS to remove non-adherent cells, and placed on a 140&#x000a0;mm culture plate. Samples were incubated in Dulbecco Modified Eagle Medium (DMEM; Gibco; Invitrogen, Paisley, UK), supplemented with sodium pyruvate (1&#x000a0;mM), L-glutamine (1&#x000a0;mM), 1&#x000a0;% penicillin/streptomycin, 10&#x000a0;% foetal calf serum (FCS), 0.4&#x000a0;% fungizone, and 1&#x000a0;% ascorbic acid. This allowed osteoblastic cells to migrate from the fragments and proliferate. After approximately 3&#x000a0;weeks of culture and before reaching confluence, total RNA was extracted using High Pure RNA Isolation kit (Roche Diagnostics, Indianapolis, USA) according to manufacturer&#x02019;s instructions. Alkaline Phosphatase activity and osteocalcin gene expression was assessed in order to confirm the osteoblastic phenotype (data not shown).</p></div><div id="Sec6" class="sec"><h3>microRNA array hybridization and data analysis</h3><p id="__p17" class="p p-first-last">Microarray procedure and data analysis were conducted at Exiqon Services, Denmark. The quality of the total RNA was verified by an Agilent 2100 Bioanalyzer profile and 250&#x000a0;ng (total bone) or 750&#x000a0;ng (primary osteoblasts) total RNA from both sample and reference was labelled with Hy3&#x02122; and Hy5&#x02122; fluorescent dyes, respectively, using the miRCURY LNA&#x02122; microRNA Hi-Power Labeling Kit, Hy3&#x02122;/Hy5&#x02122; (Exiqon, Denmark) as indicated by the manufacturer. The Hy3&#x02122;-labelled samples and a Hy5&#x02122;-labelled reference RNA sample were mixed pair-wise and hybridized to the miRCURY LNA&#x02122; microRNA Array 7th (Exiqon, Denmark), which contains capture probes targeting all human, mouse, or rat microRNAs registered in the miRBASE 18.0. The miRCURY LNA&#x02122; microRNA Array Instruction manual and a Tecan HS4800&#x02122; hybridization station (Tecan, Austria) were used for this procedure. After hybridization, the microarray slides were scanned and stored in an ozone-free environment (&#x0003c;2.0&#x000a0;ppb ozone) in order to prevent potential bleaching of the fluorescent dyes. The miRCURY LNA&#x02122; microRNA Array slides were scanned using the Agilent G2565BA Microarray Scanner System (Agilent Technologies, Inc., USA) and image analysis was carried out with ImaGene&#x000ae; 9 (miRCURY LNA&#x02122; microRNA Array Analysis Software, Exiqon, Denmark). The quantified signals were background-corrected (Normexp with offset value 10, see Ritchie et al. 2007 [<a href="#CR11" rid="CR11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_486786965">11</a>]) and normalized using the Lowess (LOcally WEighted Scatterplot Smoothing) global regression algorithm. Following normalization, both unsupervised and supervised data analysis was performed. Principal component analysis (PCA) traditional and matrix plots and heat-map hierarchical clustering were obtained. For PCA plots and the heat map, 50 mircoRNAs were used. They were chosen in an unsupervised manner by taking the normalized and background filtered data and sorting for microRNA expressed above background in all samples and with the largest standard deviation across the entire sample set. For comparison of expression levels, calculated <em>p-</em>values were based on moderated t-statistics. The threshold was set at log-fold change (log<sub>2</sub>)&#x02009;&#x0003e;&#x02009;1.5 and a <em>p</em>-value&#x02009;&#x0003c;&#x02009;0.05 (corrected by Benjamini and Hochberg [BH] multiple testing adjustment [<a href="#CR12" rid="CR12" class=" bibr popnode">12</a>]).</p></div><div id="Sec7" class="sec"><h3>Validation and replication of miRNAs by qPCR</h3><p id="__p18" class="p p-first">MiRNA qPCR and further data analyses were conducted at Exiqon Services, Denmark. Using the miRCURY LNA&#x02122; Universal RT microRNA PCR, Polyadenylation and cDNA synthesis kit (Exiqon), 10&#x000a0;ng RNA was reverse-transcribed in 10&#x000a0;&#x003bc;l reactions. cDNA was diluted 100&#x000d7; and assayed in 10&#x000a0;&#x003bc;l PCR reactions according to the protocol for miRCURY LNA&#x02122; Universal RT microRNA PCR; each microRNA was assayed once by qPCR on the microRNA Ready-to-Use PCR, custom Pick&#x00026;Mix panel using ExiLENT SYBR&#x000ae; Green mastermix. Negative controls excluding template from the reverse-transcription reaction were performed and profiled in the same way. Amplification was performed in a LightCycler&#x000ae; 480 Real-Time PCR System (Roche) in 384-well plates, and the amplification curves were analysed using the Roche LC software, both for determination of Cp (by the 2nd derivative method) and for melting curve analysis.</p><p id="__p19">The amplification efficiency was calculated using algorithms similar to the LinReg software. All assays were inspected for distinct melting curves and the Tm was checked to be within known specifications for the assay. Furthermore, assays to be included in the analysis had to be detected with 5 Cps less than the negative control and Cp&#x02009;&#x0003c;&#x02009;37. Data that did not meet all criteria were omitted from any further analysis.</p><p id="__p20">Normalization was based on the average of the references/normalizer assays detected in all samples. For the present study, the miR-let-7e-5p was used as the normalizer. Hence, the formula to calculate the normalized Cp values is [average Cp(let-7e-5p) &#x02013; assay Cp (sample)].</p><p id="__p21" class="p p-last">Data quality control, unsupervised data analysis, and Student t-test with BH correction were performed (corrected <em>p</em>-values&#x02009;&#x0003c;&#x02009;0.05 were accepted as significant).</p></div><div id="Sec8" class="sec"><h3>Bioinformatic analyses</h3><p id="__p22" class="p p-first-last">Targets for differentially expressed miRNAs were predicted using the following six programs: PicTar (<a href="http://pictar.mdc-berlin.de" ref="reftype=extlink&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">http://pictar.mdc-berlin.de</a>), TargetScan Human (<a href="http://www.targetscan.org" ref="reftype=extlink&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">http://www.targetscan.org</a>), miRDB (<a href="http://mirdb.org/" ref="reftype=extlink&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">http://mirdb.org</a>), MiRanda (<a href="http://www.microrna.org" ref="reftype=extlink&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">http://www.microrna.org</a>), DIANA-TarBase (<a href="http://diana.imis.athena-innovation.gr" ref="reftype=extlink&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">http://diana.imis.athena-innovation.gr</a>), and miRTarBase (<a href="http://mirtarbase.mbc.nctu.edu.tw" ref="reftype=extlink&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">http://mirtarbase.mbc.nctu.edu.tw</a>). The DIANA-mirPath web-based computational tool [<a href="#CR13" rid="CR13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_486786961">13</a>] was used to identify molecular pathways potentially altered by the intersection of miRNAs differentially expressed in fractured bone.</p></div><div id="Sec9" class="sec sec-last"><h3>Real-time PCR of osteoblastic markers and CD3</h3><p id="__p23" class="p p-first-last">cDNA synthesis was performed using 500&#x000a0;ng of the total extracted RNA from bone samples (OP:<em>n</em>&#x02009;=&#x02009;5; Control:<em>n</em>&#x02009;=&#x02009;6). The product was diluted (1:1) with RNAse-free pure water, and 2&#x000a0;&#x003bc;l was used to determine gene expression of BGLAP (osteocalcin), ALPL (alkaline phosphatase), COL1A1, BMP2, IGF2 and CD3D using qPCR (all reagents were obtained from Applied Biosystems). The results were analysed using ExpressionSuite Software v.1.0.3 (Life Technologies), and the expression levels were calculated against 18S expression and then normalized to an internal sample (relative quantification) using arbitrary units. All qPCR reactions for each sample were performed in triplicate. qPCR for 18S was carried out under the same conditions using an 18S endogenous control (Assay-on-Demand, Applied Biosystems). Gene expression analysis from total RNA was performed twice.</p></div></div><div id="Sec10" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec10title">Results</h2><div id="Sec11" class="sec sec-first"><h3>Sample description</h3><p id="__p24" class="p p-first-last">The anthropometric features of the OP and Control groups were shown in Table&#x000a0;<a href="/pmc/articles/PMC4640351/table/Tab1/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab1" rid-ob="ob-Tab1" co-legend-rid=""><span>1</span></a>. Using the Mann&#x02013;Whitney U test, no statistical differences in these variables were observed between the two groups.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="Tab1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p id="__p25">Patient characteristics</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139797511199360" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="2" colspan="1"></th><th rowspan="2" colspan="1">n</th><th rowspan="1" colspan="1">Age</th><th rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</th><th rowspan="1" colspan="1">BMD (g/cm<sup>2</sup>)</th></tr><tr><th rowspan="1" colspan="1">(Mean&#x02009;&#x000b1;&#x02009;SD)</th><th rowspan="1" colspan="1">(Mean&#x02009;&#x000b1;&#x02009;SD)</th><th rowspan="1" colspan="1">(Mean&#x02009;&#x000b1;&#x02009;SD)</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Discovery samples</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">Osteoporotic fracture (OP)</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">75.16&#x02009;&#x000b1;&#x02009;3.54</td><td rowspan="1" colspan="1">24.38&#x02009;&#x000b1;&#x02009;2.83</td><td rowspan="1" colspan="1">Fragility fracture</td></tr><tr><td rowspan="1" colspan="1">Control</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">72.5&#x02009;&#x000b1;&#x02009;7.42</td><td rowspan="1" colspan="1">26.06&#x02009;&#x000b1;&#x02009;3.25</td><td rowspan="1" colspan="1">0.794&#x02009;&#x000b1;&#x02009;0.074</td></tr><tr><td rowspan="1" colspan="1">Replication samples</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1">Osteoporotic fracture (OP)</td><td rowspan="1" colspan="1">7</td><td rowspan="1" colspan="1">76,29&#x02009;&#x000b1;&#x02009;7,11</td><td rowspan="1" colspan="1">27,87&#x02009;&#x000b1;&#x02009;2,57</td><td rowspan="1" colspan="1">Fragility fracture</td></tr><tr><td rowspan="1" colspan="1">Control</td><td rowspan="1" colspan="1">6</td><td rowspan="1" colspan="1">73,00&#x02009;&#x000b1;&#x02009;6,63</td><td rowspan="1" colspan="1">27,68&#x02009;&#x000b1;&#x02009;2,97</td><td rowspan="1" colspan="1">0.882&#x02009;&#x000b1;&#x02009;0.158</td></tr></tbody></table></div><div id="largeobj_idm139797511199360" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC4640351/table/Tab1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><p id="__p26">
<em>Abbreviations</em>: <em>SD</em> Standard deviation, <em>BMI</em> Body mass index, <em>BMD</em> Bone mineral density</p></div></div></div><div id="Sec12" class="sec"><h3>Unsupervised analysis of total bone miRNA array</h3><p id="__p27" class="p p-first-last">Trabecular bone samples from patients with osteoporotic fracture were analysed individually in a miRNA array and compared to samples from non-osteoporotic bone. In total, 790 miRNAs were detected when all samples were included. As a first step, an unsupervised analysis of array results based on the expression profile was performed in order to identify variation patterns related to biological or technical factors. A PCA using the 50 miRNAs with the largest variation across all samples was performed to get an overview of how the samples clustered, based on their variance (Fig.&#x000a0;<a href="/pmc/articles/PMC4640351/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span>1a</span></a>). Clustering of non-osteoporotic samples (control group) suggested a homogenous miRNA-expression profile. On the other hand, a visual cluster did not exist in the OP group samples, although they separated from controls according to PC1 (x-axis). Sample O-500, obtained from an OP patient, neither clustered with the other osteoporotic samples nor with the control group, although it behaved as a control according to PC1. This sample was considered an outlier. The heat map diagram, with a clear clustering of control samples and more disperse clustering of osteoporotic samples, corroborates the PCA results (Fig.&#x000a0;<a href="/pmc/articles/PMC4640351/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span>1b</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig1" co-legend-rid="lgnd_Fig1"><a href="/pmc/articles/PMC4640351/figure/Fig1/" target="figure" rid-figpopup="Fig1" rid-ob="ob-Fig1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139797521172416" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12920_2015_149_Fig1_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12920_2015_149_Fig1_HTML.jpg" src="/pmc/articles/PMC4640351/bin/12920_2015_149_Fig1_HTML.jpg" /></div><div id="largeobj_idm139797521172416" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC4640351/figure/Fig1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig1"><div><a class="figpopup" href="/pmc/articles/PMC4640351/figure/Fig1/" target="figure" rid-figpopup="Fig1" rid-ob="ob-Fig1">Fig. 1</a></div><!--caption a7--><div class="caption"><p id="__p28">
<strong>a</strong> PCA plot and (<strong>b</strong>) heat map diagram. Principal component analysis and clustering was performed on all samples and on the top 50 microRNAs with the highest standard deviation. Normalized log ratio values were used for the analysis. <strong>a</strong> Before the analysis, the features were shifted to be zero centered and scaled to unit variance. <strong>b</strong> Diagram shows the result of a two-way hierarchical clustering of microRNAs and samples. The clustering is done using the complete-linkage method together with the Euclidean distance. Each row represents a microRNA and each column, a sample. The microRNA clustering tree is shown on the left. The colour scale illustrates the relative level of microRNA expression: red, below the reference channel; green, higher than the reference</p></div></div></div></div><div id="Sec13" class="sec"><h3>Comparison of total bone microRNA expression between OP cases and controls</h3><p id="__p29" class="p p-first">Mean miRNA expression levels were compared between the OP and control groups, excluding sample O-500. This analysis identified a subset of 82 miRNAs (out of the 1932 miRNAs analysed) whose absolute value of log-fold change was larger than 1.5 and adjusted p-value was below 0.05 (Additional file <a href="#MOESM1" rid="MOESM1" class=" media">1</a>: Table S1). Seven of these miRNAs corresponded to SNORDs and three to viruses; all of these were excluded from the validation step.</p><p id="__p30">Eight hsa-miRNAs underwent validation in the discovery samples by qPCR (miR-675-5p, miR-30c-1-3p, miR-483-5p, miR-542-5p, miR-142-3p, miR-223-3p, miR-32-3p, and miR-320a) according to the following criteria: available Exiqon probes, the best hits in bone array (signal intensity and significant differences between the groups), and predicted to target genes involved in bone metabolism. The PCA plot of individual qPCR results showed a sample clustering similar to the array results, corroborating the different biological sources of the two sample groups (Fig.&#x000a0;<a href="/pmc/articles/PMC4640351/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span>2</span></a>). Again, sample O-500 could not be clustered with either biological group.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig2" co-legend-rid="lgnd_Fig2"><a href="/pmc/articles/PMC4640351/figure/Fig2/" target="figure" rid-figpopup="Fig2" rid-ob="ob-Fig2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139797523387232" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12920_2015_149_Fig2_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12920_2015_149_Fig2_HTML.jpg" src="/pmc/articles/PMC4640351/bin/12920_2015_149_Fig2_HTML.jpg" /></div><div id="largeobj_idm139797523387232" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC4640351/figure/Fig2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig2"><div><a class="figpopup" href="/pmc/articles/PMC4640351/figure/Fig2/" target="figure" rid-figpopup="Fig2" rid-ob="ob-Fig2">Fig. 2</a></div><!--caption a7--><div class="caption"><p id="__p31">Principal component analysis was performed on all samples. Normalized (dCp) values were used for the analysis. Bone samples from the miRNA array were used for the validation stage (OP:<em>n</em>&#x02009;=&#x02009;6; Control:<em>n</em>&#x02009;=&#x02009;6). Samples are clustered based on their biological group; however, sample O-500 appears to be an outlier</p></div></div></div><p id="__p32">In order to exclude the presence of different amount of hematopoietic cells among bone samples, especially between osteoporotic and control group, the expression of CD3 marker was analysed by qPCR. No significant differences were detected among samples neither between biological groups (Additional file <a href="#MOESM2" rid="MOESM2" class=" media">2</a>: Figure S1). Moreover, this expression was very low compared to CD3&#x02009;+&#x02009;human T-cells which were FACS sorted from peripheral blood mononuclear cells obtained from buffy coats (data not shown). Hence, differences observed among samples are not due to the blood cells present within bone fragments.</p><p id="__p33">After validation, three miRNAs &#x02013;miR-30c-1-3p, miR-320a, and miR-483-5p&#x02013; showed significant differences between the OP and control groups (Table&#x000a0;<a href="/pmc/articles/PMC4640351/table/Tab2/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab2" rid-ob="ob-Tab2" co-legend-rid=""><span>2</span></a>). However, only miR-320a and miR-483-5p withstood BH multiple-testing correction (Fig.&#x000a0;<a href="/pmc/articles/PMC4640351/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span>3</span></a>).</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="Tab2"><h3>Table 2</h3><!--caption a7--><div class="caption"><p id="__p34">qPCR-validated miRNAs that reached significance in the microRNA array</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139797519533600" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1"></th><th colspan="2" rowspan="1">Average dCp</th><th colspan="4" rowspan="1">ddCp</th></tr><tr><th rowspan="2" colspan="1">miR name</th><th rowspan="1" colspan="1">Control</th><th rowspan="1" colspan="1">OP</th><th rowspan="2" colspan="1">LogFC</th><th rowspan="2" colspan="1">SD</th><th rowspan="2" colspan="1">P</th><th rowspan="1" colspan="1">BH adj.</th></tr><tr><th rowspan="1" colspan="1">(<em>n</em>&#x02009;=&#x02009;6)</th><th rowspan="1" colspan="1">(<em>n</em>&#x02009;=&#x02009;5)</th><th rowspan="1" colspan="1">
<em>p-</em>value</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">hsa-miR-320a</td><td rowspan="1" colspan="1">2.08</td><td rowspan="1" colspan="1">5.42</td><td rowspan="1" colspan="1">&#x02212;3.34</td><td rowspan="1" colspan="1">1.88</td><td rowspan="1" colspan="1">5.89E-05</td><td rowspan="1" colspan="1">5.30E-04</td></tr><tr><td rowspan="1" colspan="1">hsa-miR-483-5p</td><td rowspan="1" colspan="1">&#x02212;4.48</td><td rowspan="1" colspan="1">&#x02212;1.16</td><td rowspan="1" colspan="1">&#x02212;3.32</td><td rowspan="1" colspan="1">1.98</td><td rowspan="1" colspan="1">1.59E-04</td><td rowspan="1" colspan="1">7.17E-04</td></tr><tr><td rowspan="1" colspan="1">hsa-miR-30c-1-3p</td><td rowspan="1" colspan="1">&#x02212;7.25</td><td rowspan="1" colspan="1">&#x02212;5.50</td><td rowspan="1" colspan="1">&#x02212;1.75</td><td rowspan="1" colspan="1">1.28</td><td rowspan="1" colspan="1">4.62E-02</td><td rowspan="1" colspan="1">6.93E-02</td></tr><tr><td rowspan="1" colspan="1">hsa-miR-32-3p</td><td rowspan="1" colspan="1">&#x02212;4.92</td><td rowspan="1" colspan="1">&#x02212;3.76</td><td rowspan="1" colspan="1">&#x02212;1.16</td><td rowspan="1" colspan="1">1.36</td><td rowspan="1" colspan="1">1.39E-01</td><td rowspan="1" colspan="1">6.93E-02</td></tr><tr><td rowspan="1" colspan="1">hsa-miR-142-3p</td><td rowspan="1" colspan="1">4.39</td><td rowspan="1" colspan="1">4.38</td><td rowspan="1" colspan="1">0.01</td><td rowspan="1" colspan="1">1.07</td><td rowspan="1" colspan="1">9.86E-01</td><td rowspan="1" colspan="1">6.93E-02</td></tr><tr><td rowspan="1" colspan="1">hsa-miR-223-3p</td><td rowspan="1" colspan="1">8.05</td><td rowspan="1" colspan="1">7.67</td><td rowspan="1" colspan="1">0.38</td><td rowspan="1" colspan="1">1.57</td><td rowspan="1" colspan="1">7.48E-01</td><td rowspan="1" colspan="1">8.26E-01</td></tr><tr><td rowspan="1" colspan="1">hsa-miR-542-5p</td><td rowspan="1" colspan="1">&#x02212;3.34</td><td rowspan="1" colspan="1">&#x02212;3.22</td><td rowspan="1" colspan="1">&#x02212;0.12</td><td rowspan="1" colspan="1">0.73</td><td rowspan="1" colspan="1">8.26E-01</td><td rowspan="1" colspan="1">8.26E-01</td></tr><tr><td rowspan="1" colspan="1">hsa-miR-675-5p</td><td rowspan="1" colspan="1">&#x02212;6.48</td><td rowspan="1" colspan="1">&#x02212;4.87</td><td rowspan="1" colspan="1">&#x02212;1.61</td><td rowspan="1" colspan="1">1.16</td><td colspan="2" rowspan="1">Not calculated<sup>a</sup>
</td></tr></tbody></table></div><div id="largeobj_idm139797519533600" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC4640351/table/Tab2/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><p id="__p35">
<sup>a</sup>miR-675-5p was detected in a low number of samples, which precluded statistical comparison between groups</p></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig3" co-legend-rid="lgnd_Fig3"><a href="/pmc/articles/PMC4640351/figure/Fig3/" target="figure" rid-figpopup="Fig3" rid-ob="ob-Fig3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139797523128624" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12920_2015_149_Fig3_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12920_2015_149_Fig3_HTML.jpg" src="/pmc/articles/PMC4640351/bin/12920_2015_149_Fig3_HTML.jpg" /></div><div id="largeobj_idm139797523128624" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC4640351/figure/Fig3/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig3"><div><a class="figpopup" href="/pmc/articles/PMC4640351/figure/Fig3/" target="figure" rid-figpopup="Fig3" rid-ob="ob-Fig3">Fig. 3</a></div><!--caption a7--><div class="caption"><p id="__p36">miR-320a and miR-483-5p were validated by qPCR. Relative expression levels of miR-320a and miR-483-5p at the validation stage in patients with osteoporotic fracture (<em>n</em>&#x02009;=&#x02009;5) and controls (<em>n</em>&#x02009;=&#x02009;6). miRNA let-7e-5p was used as a normalizer</p></div></div></div><p id="__p37" class="p p-last">The replication samples were added in the analysis in order to increase the sample size. The miR-320a (<em>p</em>&#x02009;=&#x02009;0.005) and miR-483-5p (<em>p</em>&#x02009;=&#x02009;0.036) still showed significant differences between biological groups.</p></div><div id="Sec14" class="sec"><h3>Expression of IGF2 in total bone mRNA from OP cases and controls</h3><p id="__p38" class="p p-first-last">Since miRNA miR-483-5p is located within intron 2 of <em>IGF2,</em> the expression of this gene was assessed by qPCR to assess its co-expression with miR-483-5p. In the OP samples, <em>IGF2</em> was under-expressed compared to control samples (Fig.&#x000a0;<a href="/pmc/articles/PMC4640351/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span>4</span></a>). Thus, <em>IGF2</em> did not show the over-expression found for miR-483-5p in the OP group, instead showing a trend in the opposite direction. BMP2, COL1A1, alkaline phosphatase, and osteocalcin gene expression were also evaluated in OP and control samples as disease reference markers. All four showed diminished levels in the osteoporotic bone, as expected (Fig.&#x000a0;<a href="/pmc/articles/PMC4640351/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span>4</span></a>). Although a trend is clearly detected in all genes tested, the limited sample size and experiment replication did not allow sufficient power to reach statistical differences between the biological groups.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig4" co-legend-rid="lgnd_Fig4"><a href="/pmc/articles/PMC4640351/figure/Fig4/" target="figure" rid-figpopup="Fig4" rid-ob="ob-Fig4"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139797521975024" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12920_2015_149_Fig4_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12920_2015_149_Fig4_HTML.jpg" src="/pmc/articles/PMC4640351/bin/12920_2015_149_Fig4_HTML.jpg" /></div><div id="largeobj_idm139797521975024" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC4640351/figure/Fig4/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig4"><div><a class="figpopup" href="/pmc/articles/PMC4640351/figure/Fig4/" target="figure" rid-figpopup="Fig4" rid-ob="ob-Fig4">Fig. 4</a></div><!--caption a7--><div class="caption"><p id="__p39">Gene expression quantification of osteoblastic markers by Real-Time PCR in total bone samples. <em>ALPL, BMP2, COL1A1, BGLAP,</em> and <em>IGF2</em> gene expression was quantified in osteoporotic (OP) samples (<em>n</em>&#x02009;=&#x02009;5) and compared to osteoarthritic (control) samples (<em>n</em>&#x02009;=&#x02009;6). 18S was used as endogenous control. Results are expressed as mean and standard error</p></div></div></div></div><div id="Sec15" class="sec"><h3>MicroRNA array profiling of cultured primary osteoblasts</h3><p id="__p40" class="p p-first-last">To determine which of the total bone miRNAs were expressed in osteoblasts, miRNA profiling of four hOB samples in passage 0 was performed. A total of 315 miRNAs were detected in osteoblasts, of which 293 (93&#x000a0;%) were also detected in total bone samples (Fig.&#x000a0;<a href="/pmc/articles/PMC4640351/figure/Fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig5" rid-ob="ob-Fig5" co-legend-rid="lgnd_Fig5"><span>5</span></a>). These 293 osteoblastic miRNAs represent a 37&#x000a0;% of all 790 bone miRNAs. Regarding the 82 miRNAs differentially expressed between control and OP samples, 46 were also detected in the osteoblast array, including miR-320a and miR-483-5p. Interestingly, 22 miRNAs found in the hOB array were not detected in total bone.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig5" co-legend-rid="lgnd_Fig5"><a href="/pmc/articles/PMC4640351/figure/Fig5/" target="figure" rid-figpopup="Fig5" rid-ob="ob-Fig5"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139797520562256" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12920_2015_149_Fig5_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12920_2015_149_Fig5_HTML.jpg" src="/pmc/articles/PMC4640351/bin/12920_2015_149_Fig5_HTML.jpg" /></div><div id="largeobj_idm139797520562256" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC4640351/figure/Fig5/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig5"><div><a class="figpopup" href="/pmc/articles/PMC4640351/figure/Fig5/" target="figure" rid-figpopup="Fig5" rid-ob="ob-Fig5">Fig. 5</a></div><!--caption a7--><div class="caption"><p id="__p41">Venn diagram of total bone and osteoblast miRNAs detected in the array</p></div></div></div></div><div id="Sec16" class="sec sec-last"><h3>Target prediction and pathway analysis for differentially expressed miRNAs</h3><p id="__p42" class="p p-first">A comprehensive bioinformatics analysis using six different programs allowed us to predict putative targets for the two differentially expressed miRNAs identified. Targets predicted and validated for miR-320a are involved in a variety of cellular processes, including cell proliferation (SRF, ARPP-19, PDGFD) and apoptosis inhibition (MCL1), signal transduction (MAPK1, SGK, DNER, JAK2), gene expression regulation (PPARGC1A, SP1, CAMTA1, ESRRG), growth factors (IGF1, BMP3 and 6), and hormone, growth factor, and cytokine receptors (LEPR, NR3C1, BMPR1A, RARG, RXRA, IGF1R, IL6R, PTGER3, TFR1). This miRNA is involved in 45 KEGG pathways according to DIANA-mirPath predictions, the most significant being prostate cancer (6.436856e-14), endometrial cancer (4.517902e-10), mTOR signalling pathway (1.336018e-07), and PI3K-Akt signalling pathway (2.347282e-07).</p><p id="__p43">Cell proliferation factors such as SRF and MAPK3 (mirTArBase) are validated targets for the less-studied miR-483-5p. KEGG pathways involving miR-483-5p target genes are mainly ECM-receptor interaction (0.00114789) and N-Glycan biosynthesis (5.118433e-07), as well as PI3K-Akt signalling (0.01153999) and focal adhesion (0.002081914) (DIANA-mirPath).</p><p id="__p44" class="p p-last">The intersection pathways involving genes targeted by miR-320a and miR-483-5p are mainly prostate cancer (4.496403e-14), PI3K-Akt signalling (5.614388e-08), and focal adhesion (6.000918e-07). Genes belonging to the mentioned pathways which are targeted by these two miRNAs are shown in Fig.&#x000a0;<a href="/pmc/articles/PMC4640351/figure/Fig6/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig6" rid-ob="ob-Fig6" co-legend-rid="lgnd_Fig6"><span>6</span></a>.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig6" co-legend-rid="lgnd_Fig6"><a href="/pmc/articles/PMC4640351/figure/Fig6/" target="figure" rid-figpopup="Fig6" rid-ob="ob-Fig6"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139797524170464" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12920_2015_149_Fig6_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12920_2015_149_Fig6_HTML.jpg" src="/pmc/articles/PMC4640351/bin/12920_2015_149_Fig6_HTML.jpg" /></div><div id="largeobj_idm139797524170464" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC4640351/figure/Fig6/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig6"><div><a class="figpopup" href="/pmc/articles/PMC4640351/figure/Fig6/" target="figure" rid-figpopup="Fig6" rid-ob="ob-Fig6">Fig. 6</a></div><!--caption a7--><div class="caption"><p id="__p45">Schematic pathway involving miR320a and miR483-5p target genes. miR-320a target genes are shown in white boxes, miR-483-5p target genes in grey boxes and the black box shows a common target gene for both miRNAs</p></div></div></div></div></div><div id="Sec17" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec17title">Discussion</h2><p id="__p46" class="p p-first">The present study is focused on the identification of miRNAs with altered expression in osteoporotic bone. Fresh trabecular bone was collected from patients with and without osteoporotic fracture with homogenous anthropometric parameters such as age, BMI, gender or disorders affecting bone remodelling. These accurate selection criteria of samples allowed us to identify, unlike previous studies, miRNAs altered due to osteoporotic fracture specifically. The results obtained can help to identify putative targets for new therapeutic approaches.</p><p id="__p47">The unsupervised analysis of the miRNA profiling from total bone samples showed that osteoporotic bone clearly differed from control samples, which were able to generate a biological cluster. In contrast, osteoporotic samples presented a much more scattered distribution. It is tempting to speculate that the pathophysiology of the osteoporotic disease and ultimately the bone fracture has a heterogeneous aetiology illustrated by different miRNA expression patterns. Working with human samples of fresh bone directly obtained from fractured sites generates higher variability than working with cell lines or isogeneic animal models, but provides a scenario closer to the pathophysiological situation. Hence, our study is based on human bone samples obtained with minimal laboratory manipulation.</p><p id="__p48">In the analysis of differential expression between osteoporotic and control samples, 82 miRNAs reached significance, and after qPCR validation, two miRNAs were significantly over-expressed in osteoporotic samples (miR-320a and miR-483-5p). Both miRNAs were found in the hOB array, suggesting a possible alteration in the osteoblastic cell function. However, since these miRNAs are known to be expressed in a wide variety of cell types, we cannot rule out their expression in other bone cells, and hence a wider spectrum of bone cellular dysfunction. Another miRNA, miR-30c-1-3p, was also over-expressed in osteoporotic samples, although this did not withstand multiple-testing correction. miR-30c-1-3p was not detected in the hOB array. This may suggest a hematopoietic origin for this miRNA since it was reported in macrophages [<a href="#CR14" rid="CR14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_486786968">14</a>] and NK cells [<a href="#CR15" rid="CR15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_486786989">15</a>].</p><p id="__p49">According to our results, 37&#x000a0;% of total bone miRNAs are expressed in bone-forming cells. There are 22 miRNAs detected in the hOB array that were not found in total bone. It may be that hOB cultures, grown in a homogenous and controlled environment, allow for the detection of low-expressed osteoblast-specific miRNAs, which would be diluted in total trabecular bone. Alternatively, <em>in vitro</em> conditions of cultured cells may create an artificial environment leading to an altered miRNA expression.</p><p id="__p50">miR-320a, which is conserved in human, mouse, rat, and cow, is encoded within the basal promoter of the cell-cycle gene <em>POLR3D</em> in the anti-sense orientation. Interestingly, this miRNA targets the <em>POLR3D</em> promoter in cis with perfect complementarity, leading to its direct transcriptional silencing [<a href="#CR16" rid="CR16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_486786991">16</a>]. miR-320a has been extensively studied, both in cancer and in osteoblastic cell function. Some reports indicate that this miRNA may regulate the osteoblast differentiation [<a href="#CR17" rid="CR17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_486786982">17</a>] by targeting key bone-formation genes such as <em>CTNNB1</em> (B-catenin) [<a href="#CR18" rid="CR18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_486786979">18</a>] and <em>RUNX2</em> [<a href="#CR19" rid="CR19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_486786993">19</a>]. In this context, Hamam et al. [<a href="#CR20" rid="CR20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_486786967">20</a>] observed that miR-320 family (miR-320a, 320b, 320c, 320d and 320e) were upregulated during adipogenesis suggesting the miR-320 family as possible molecular switch promoting adipocytic differentiation of hMSC by targeting <em>RUNX2, MIB1, PAX6, YWHAH</em> and <em>ZWILCH</em>.</p><p id="__p51">miR-483-5p has been associated with several pathological conditions, including tumours such as adrenocortical and ovarian serous carcinoma [<a href="#CR21" rid="CR21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_486786980">21</a>, <a href="#CR22" rid="CR22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_486786964">22</a>], cartilage-associated pathologies such as multiple osteochondroma [<a href="#CR23" rid="CR23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_486786978">23</a>] and osteoarthritic chondrocytes [<a href="#CR24" rid="CR24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_486786988">24</a>]. This miRNA has also been detected in human osteosarcoma cells [<a href="#CR25" rid="CR25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_486786983">25</a>]. MiR-483 is encoded within the second intron of the <em>IGF2</em> gene. The pre-miRNA generates two mature miRNAs, miR-483-5p and miR-483-3p, both of them present in the bone and hOB profiles of this study, although only miR-483-5p showed significant differences between the control and OP groups. Liu et al. [<a href="#CR26" rid="CR26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_486786971">26</a>] demonstrated that miR-483-5p binds to the 5&#x02019;-UTR of the major foetal <em>IGF2</em> promoter transcript, enhancing the association of the RNA helicase DHX9 to the <em>IGF2</em> mRNA and leading to its up-regulation. However, miR-483-5p does not act on promoters that drive adult <em>IGF2</em> expression. In mouse Hepa1-6 cells, Ma et al. [<a href="#CR27" rid="CR27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_486786972">27</a>] determined that miR-483-5p is transcriptionally co-expressed with its host gene, <em>Igf2</em>, and negatively regulates it. The same pattern of regulation was observed in cartilage samples from old mice and murine osteoarthritic cartilage, in which there were higher levels of miR-483 (orthologous to hsa-miR-483-5p) and lower mRNA levels of <em>Igf2</em> [<a href="#CR28" rid="CR28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_486786984">28</a>]. In agreement with these data from the murine system, when we tested <em>IGF2</em> mRNA levels in the osteoporotic bone samples, in which miR-483-5p was up-regulated, we observed a trend of reduction relative to controls (see Fig.&#x000a0;<a href="/pmc/articles/PMC4640351/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span>4</span></a>). To our knowledge, this is the first time in which this miRNA that down-regulates <em>IGF2</em> is found over-expressed in osteoporotic bone. Osteoblasts synthesize IGF-I and IGF-II, which have mitogenic effects on bone cells and also promote collagen production and matrix apposition [<a href="#CR29" rid="CR29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_486786992">29</a>]. We tested osteoblastic markers in our samples of total fresh bone in order to compare the osteoblastic function between biological groups. Visibly, the gene expression results showed a diminished expression of all tested markers (<em>BMP2</em>, <em>COL1A1</em>, alkaline phosphatase, and osteocalcin), corroborating the abnormal functionality of osteoporotic bone samples used in this study. However, the limited sample size does not allow sufficient statistical power to determine significant differences between groups in these qPCR results.</p><p id="__p52">When the intersection of the pathways targeted by miR-320a and miR-483-5p were explored, prostate cancer, PI3K-Akt signalling, and focal adhesion emerged as the most significant. These three pathways share many genes: <em>SOS2, IGF1R, PDK1, PDGFD, PIK3CA, AKT3, PTEN,</em> and <em>MAPK1</em>. Most of them belong to cell proliferation and survival signalling, suggesting a dysfunction in the osteoblastic cell renewal in the osteoporotic bone.</p><p id="__p53">Regarding miR-30c-1-3p (miR-30c-1*), it is an intronic miRNA encoded within the <em>NFYC</em> (nuclear transcription factor Y, gamma) gene. Although it did not withstand multiple-testing correction, it is worth noting that the analysis of targeted genes for this miRNA showed that Wnt signalling is the most significantly affected pathway, containing up to eight targeted genes. The key role of this pathway in bone remodelling is well known [<a href="#CR30" rid="CR30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_486786966">30</a>].</p><p id="__p54">Very recently, Seeliger et al. [<a href="#CR7" rid="CR7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_486786990">7</a>] and Garmilla-Ezquerra et al. [<a href="#CR8" rid="CR8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_486786977">8</a>] performed a microRNA analyses from total bone tissue comparing osteoporotic vs non-osteoporotic bone, resulting in different miRNA expression pattern compared to our findings. Remarkably, these two previous studies have several features that can explain these discrepancies. Among them are the diverse experimental approaches, arrays, and sample sizes used. Moreover, these previous studies compared patients with non-homogeneous anthropometric or clinical characteristics, such as age, sex, BMI, and endocrinology disorders (diabetes mellitus), which are essential for the regulation of bone metabolism. Therefore, it might be that their findings had been interfered by these external conditions while we stressed on the absence of concomitant diseases or external factors that potentially could induce noise.</p><p id="__p55">An important strength of our study is the extremely careful control of potentially confounding characteristics between cases and controls in terms of age, sex, BMI and metabolic diseases highly prevalent in this population as diabetes. These strict inclusion criteria explain the relatively small sample size in our study, compared to other similar works where samples are from patients with more heterogeneous characteristics. Therefore, the miRNAs detected in our study can be more reliably considered involved in the osteoporotic phenotype. On the other hand, a possible limitation of our approach is that the non-fractured patients used as controls were osteoarthritic and other bone abnormalities may be occurring in this group. Due to obvious ethical reasons the collection of fresh bone from joint samples of healthy individuals is not allowed. However, in an attempt to minimize this potential caveat, we were careful in obtaining the bone samples from a location distant from the interface between bone and cartilage and, therefore, as far away as possible from the osteoarthritic lesion.</p><p id="__p56" class="p p-last">At this stage of miRNA discovery, results from our study and others offer an important breakthrough for the understanding of miRNA biology and pathology in bone. While serum analysis could be interesting to find biomarkers, extensive analyses of osteoporosis-related miRNAs in bone tissue is required to better understand the role of miRNAs in the disease and to explore the potential to design local therapeutic approaches.</p></div><div id="Sec18" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec18title">Conclusions</h2><p id="__p57" class="p p-first">We have identified two miRNAs over-expressed in bone samples from patients with osteoporosis and fracture compared to patients with osteoarthritis in the absence of osteoporosis. The expression of both miRNAs has been detected in osteoblasts. Both are putative regulators of key genes required for bone metabolism. Whether these altered miRNAs are a cause or a consequence of the disease remains to be elucidated. Nonetheless, they might offer promising potential as therapeutic targets in osteoporosis.</p><div id="Sec19" class="sec sec-last"><h3>Availability of supporting information</h3><p id="__p58" class="p p-first-last">The data sets supporting the results of this article are available in the NCBI GEO repository and are accessible through GEO accession number <a id="__tag_486786995" class="tag_hotlink" href="/geo/query/acc.cgi?acc=GSE74209" ref="/geo/query/acc.cgi?acc=GSE74209"><span class="tag-json" style="display:none">{"type":"entrez-geo","attrs":{"text":"GSE74209","term_id":"74209"}}</span>GSE74209</a> for whole trabecular bone miRNA array (<a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE74209" ref="reftype=extlink&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=<a id="__tag_486786994" class="tag_hotlink" href="/geo/query/acc.cgi?acc=GSE74209" ref="/geo/query/acc.cgi?acc=GSE74209"><span class="tag-json" style="display:none">{"type":"entrez-geo","attrs":{"text":"GSE74209","term_id":"74209"}}</span>GSE74209</a></a>) and <a id="__tag_486786996" class="tag_hotlink" href="/geo/query/acc.cgi?acc=GSE74211" ref="/geo/query/acc.cgi?acc=GSE74211"><span class="tag-json" style="display:none">{"type":"entrez-geo","attrs":{"text":"GSE74211","term_id":"74211"}}</span>GSE74211</a> for primary human osteoblasts miRNA array (<a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE74211" ref="reftype=extlink&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI&amp;rendering-type=normal" target="_blank">http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=<a id="__tag_486786997" class="tag_hotlink" href="/geo/query/acc.cgi?acc=GSE74211" ref="/geo/query/acc.cgi?acc=GSE74211"><span class="tag-json" style="display:none">{"type":"entrez-geo","attrs":{"text":"GSE74211","term_id":"74211"}}</span>GSE74211</a></a>).</p></div></div><div id="idm139797525878176" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139797525878176title">Acknowledgments</h2><div class="sec"><p id="__p66">The authors thank Elaine M. Lilly, Ph.D, for helpful advice and critical reading of the manuscript and Lara Nonell Mazel&#x000f3;n (IMIM) for her support in bioinformatics tools.</p><div id="FPar1" class="sec"><h2>Funding</h2><p id="__p67" class="p p-first-last">This work was supported by grant FIS PI10/01537 and the Red Tem&#x000e1;tica de Investigaci&#x000f3;n Cooperativa en Envejecimiento y Fragilidad (RETICEF) (Carlos III Health Institute, Science and Innovation Ministry), and FEDER funds. Grant SAF2011-25431 and PIB2010AR-00473 (Science and Innovation Ministry), and the support from the Centro de Investigaci&#x000f3;n Biom&#x000e9;dica en Red de Enfermedades Raras (CIBERER, an initiative of ISCIII) are also acknowledged. Grants from the Generalitat de Catalunya (DIUE; 2009 SGR 818, 2009 SGR 971) also supported this work.</p></div></div></div><div id="App1" class="tsec sec headless whole_rhythm"><!--/article/back/app-group/app/--><div id="Sec20" class="sec sec-first"><h3>Additional files</h3><p id="__p59" class="p p-first-last"><span class="sup-box" id="MOESM1"><a href="/pmc/articles/PMC4640351/bin/12920_2015_149_MOESM1_ESM.docx">Additional file 1: Table S1.</a><sup>(39K, docx)</sup><p id="__p60">Significant differentially expressed miRNAs between osteoporotic and control bone samples. Logarithmic fold change (logFC); adjusted P. Value (adj.P. Val); standard deviation (SD). (DOCX 38 kb)</p></span><span class="sup-box" id="MOESM2"><a href="/pmc/articles/PMC4640351/bin/12920_2015_149_MOESM2_ESM.docx">Additional file 2: Figure S1.</a><sup>(59K, docx)</sup><p id="__p61">Gene expression quantification of CD3 marker by Real-Time PCR in total bone samples. OP samples (<em>n</em>&#x02009;=&#x02009;3); Osteoarthritic (control) samples (<em>n</em>&#x02009;=&#x02009;6). Results are expressed as mean of relative expression and standard deviation. A) Gene expression in each bone sample; B) Gene expression comparison between biological groups. (DOCX 59 kb)</p></span></p></div></div><div id="idm139797521731680" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139797521731680title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="idm139797521731552"><p id="__p62" class="p p-first"><strong>Competing interests</strong></p><p id="__p63" class="p p-last">The authors declared that they have no competing interests.</p></p><p class="fn sec" id="idm139797521730304"><p id="__p64" class="p p-first"><strong>Authors&#x02019; contributions</strong></p><p id="__p65" class="p p-last">Conceived and designed the experiments: LDU, NGG, GY. Performed the experiments: LDU, NGG. Analysed the data: SB, DG, LDU, NGG. Contributed reagents/materials/analysis tools/acquisition of data: SMD, XN, LM, AD, RGF. Interpretation of data and help to draft the manuscript: RU, NGG, LDU. Contributed to the writing of the manuscript: SB, DG, AD, LDU, NGG. All authors read and approved the final manuscript.</p></p></div></div><div id="idm139797595297632aff-info" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139797595297632aff-infotitle">Contributor Information</h2><p><span class="fm-affl">Laura De-Ugarte, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="se.mimi@etraguedl" class="oemail">se.mimi@etraguedl</a></span>.</p><p><span class="fm-affl">Guy Yoskovitz, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.liamg@ztivoksoy.yug" class="oemail">moc.liamg@ztivoksoy.yug</a></span>.</p><p><span class="fm-affl">Susana Balcells, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.bu@slleclabs" class="oemail">ude.bu@slleclabs</a></span>.</p><p><span class="fm-affl">Robert G&#x000fc;erri-Fern&#x000e1;ndez, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="se.mimi@irreugr" class="oemail">se.mimi@irreugr</a></span>.</p><p><span class="fm-affl">Santos Martinez-Diaz, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="tac.ramtulasedcrap@46049" class="oemail">tac.ramtulasedcrap@46049</a></span>.</p><p><span class="fm-affl">Leonardo Mellibovsky, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="tac.ramtulasedcrap@47181" class="oemail">tac.ramtulasedcrap@47181</a></span>.</p><p><span class="fm-affl">Roser Urreizti, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.bu@itzierru" class="oemail">ude.bu@itzierru</a></span>.</p><p><span class="fm-affl">Xavier Nogu&#x000e9;s, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="tac.ramtulasedcrap@28358" class="oemail">tac.ramtulasedcrap@28358</a></span>.</p><p><span class="fm-affl">Daniel Grinberg, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.bu@grebnirgd" class="oemail">ude.bu@grebnirgd</a></span>.</p><p><span class="fm-affl">Natalia Garc&#x000ed;a-Giralt, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="se.mimi@aicragn" class="oemail">se.mimi@aicragn</a></span>.</p><p><span class="fm-affl">Adolfo D&#x000ed;ez-P&#x000e9;rez, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="tac.ramtulasedcrap@zeiDA" class="oemail">tac.ramtulasedcrap@zeiDA</a></span>.</p></div><div id="Bib1" class="tsec sec"><h2 class="head no_bottom_margin" id="Bib1title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="CR1">1. <span class="element-citation">Zhang B, Pan X, Cobb GP, Anderson TA. microRNAs as oncogenes and tumor suppressors. <span><span class="ref-journal">Dev Biol. </span>2007;<span class="ref-vol">302</span>(1):1–12. doi: 10.1016/j.ydbio.2006.08.028.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/16989803" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1016%2Fj.ydbio.2006.08.028" target="pmc_ext" ref="reftype=other&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR2">2. <span class="element-citation">Lian JB, Stein GS, van Wijnen AJ, Stein JL, Hassan MQ, Gaur T, et al.  MicroRNA control of bone formation and homeostasis. <span><span class="ref-journal">Nat Rev Endocrinol. </span>2012;<span class="ref-vol">8</span>(4):212–227. doi: 10.1038/nrendo.2011.234.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC3589914/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/22290358" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1038%2Fnrendo.2011.234" target="pmc_ext" ref="reftype=other&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR3">3. <span class="element-citation">Taipaleenmaki H, Bjerre Hokland L, Chen L, Kauppinen S, Kassem M. Mechanisms in endocrinology: micro-RNAs: targets for enhancing osteoblast differentiation and bone formation. <span><span class="ref-journal">Eur J Endocrinol. </span>2012;<span class="ref-vol">166</span>(3):359–371. doi: 10.1530/EJE-11-0646.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/22084154" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1530%2FEJE-11-0646" target="pmc_ext" ref="reftype=other&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR4">4. <span class="element-citation">van Wijnen AJ, van de Peppel J, van Leeuwen JP, Lian JB, Stein GS, Westendorf JJ, et al.  MicroRNA functions in Osteogenesis and dysfunctions in osteoporosis. <span><span class="ref-journal">Curr Osteoporos Rep. </span>2013;<span class="ref-vol">11</span>(2):72–82. doi: 10.1007/s11914-013-0143-6.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC3678273/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/23605904" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1007%2Fs11914-013-0143-6" target="pmc_ext" ref="reftype=other&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR5">5. <span class="element-citation">Li H, Xie H, Liu W, Hu R, Huang B, Tan YF, et al.  A novel microRNA targeting HDAC5 regulates osteoblast differentiation in mice and contributes to primary osteoporosis in humans. <span><span class="ref-journal">J Clin Invest. </span>2009;<span class="ref-vol">119</span>(12):3666–3677. doi: 10.1172/JCI39832.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC2786801/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/19920351" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1172%2FJCI39832" target="pmc_ext" ref="reftype=other&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR6">6. <span class="element-citation">Lei SF, Papasian CJ, Deng HW. Polymorphisms in predicted miRNA binding sites and osteoporosis. <span><span class="ref-journal">J Bone Miner Res. </span>2011;<span class="ref-vol">26</span>(1):72–78. doi: 10.1002/jbmr.186.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC3179316/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/20641033" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1002%2Fjbmr.186" target="pmc_ext" ref="reftype=other&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR7">7. <span class="mixed-citation">Seeliger C, Karpinski K, Haug A, Vester H, Schmitt A, Bauer J, et al. Five freely circulating miRNAs and bone tissue miRNAs are associated with Osteoporotic fractures. J Bone Miner Res. 2014.  <span class="nowrap ref pubmed">[<a href="/pubmed/24431276" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR8">8. <span class="element-citation">Garmilla-Ezquerra P, Sanudo C, Delgado-Calle J, Perez-Nunez MI, Sumillera M, Riancho JA. Analysis of the bone MicroRNome in Osteoporotic fractures. <span><span class="ref-journal">Calcif Tissue Int. </span>2014</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/25432767" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR9">9. <span class="element-citation">Guo L, Zhao RC, Wu Y. The role of microRNAs in self-renewal and differentiation of mesenchymal stem cells. <span><span class="ref-journal">Exp Hematol. </span>2011;<span class="ref-vol">39</span>(6):608–616. doi: 10.1016/j.exphem.2011.01.011.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/21288479" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1016%2Fj.exphem.2011.01.011" target="pmc_ext" ref="reftype=other&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR10">10. <span class="element-citation">Kapinas K, Delany AM. MicroRNA biogenesis and regulation of bone remodeling. <span><span class="ref-journal">Arthritis Res Ther. </span>2011;<span class="ref-vol">13</span>(3):220. doi: 10.1186/ar3325.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC3218876/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/21635717" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1186%2Far3325" target="pmc_ext" ref="reftype=other&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR11">11. <span class="element-citation">Ritchie ME, Silver J, Oshlack A, Holmes M, Diyagama D, Holloway A, et al.  A comparison of background correction methods for two-colour microarrays. <span><span class="ref-journal">Bioinformatics. </span>2007;<span class="ref-vol">23</span>(20):2700–2707. doi: 10.1093/bioinformatics/btm412.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/17720982" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1093%2Fbioinformatics%2Fbtm412" target="pmc_ext" ref="reftype=other&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR12">12. <span class="element-citation">Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. <span><span class="ref-journal">J Royal Stat Soc B. </span>1995;<span class="ref-vol">57</span>:289–300.</span></span></div><div class="ref-cit-blk half_rhythm" id="CR13">13. <span class="element-citation">Vlachos IS, Kostoulas N, Vergoulis T, Georgakilas G, Reczko M, Maragkakis M, et al.  DIANA miRPath v.2.0: investigating the combinatorial effect of microRNAs in pathways. <span><span class="ref-journal">Nucleic Acids Res. </span>2012;<span class="ref-vol">40</span>(Web Server issue):W498–W504. doi: 10.1093/nar/gks494.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC3394305/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/22649059" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1093%2Fnar%2Fgks494" target="pmc_ext" ref="reftype=other&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR14">14. <span class="element-citation">Cai Y, Chen H, Jin L, You Y, Shen J. STAT3-dependent transactivation of miRNA genes following Toxoplasma gondii infection in macrophage. <span><span class="ref-journal">Parasit Vectors. </span>2013;<span class="ref-vol">6</span>:356. doi: 10.1186/1756-3305-6-356.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC3878672/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/24341525" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1186%2F1756-3305-6-356" target="pmc_ext" ref="reftype=other&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR15">15. <span class="element-citation">Gong J, Liu R, Zhuang R, Zhang Y, Fang L, Xu Z, et al.  miR-30c-1* promotes natural killer cell cytotoxicity against human hepatoma cells by targeting the transcription factor HMBOX1. <span><span class="ref-journal">Cancer Sci. </span>2012;<span class="ref-vol">103</span>(4):645–652. doi: 10.1111/j.1349-7006.2012.02207.x.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/22320217" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1111%2Fj.1349-7006.2012.02207.x" target="pmc_ext" ref="reftype=other&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR16">16. <span class="element-citation">Kim DH, Saetrom P, Snove O, Jr, Rossi JJ. MicroRNA-directed transcriptional gene silencing in mammalian cells. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2008;<span class="ref-vol">105</span>(42):16230–16235. doi: 10.1073/pnas.0808830105.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC2571020/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/18852463" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1073%2Fpnas.0808830105" target="pmc_ext" ref="reftype=other&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR17">17. <span class="element-citation">Gordeladze JO, Reseland JE, Duroux-Richard I, Apparailly F, Jorgensen C. From stem cells to bone: phenotype acquisition, stabilization, and tissue engineering in animal models. <span><span class="ref-journal">ILAR J. </span>2009;<span class="ref-vol">51</span>(1):42–61. doi: 10.1093/ilar.51.1.42.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/20075497" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1093%2Filar.51.1.42" target="pmc_ext" ref="reftype=other&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR18">18. <span class="element-citation">Sun JY, Huang Y, Li JP, Zhang X, Wang L, Meng YL, et al.  MicroRNA-320a suppresses human colon cancer cell proliferation by directly targeting beta-catenin. <span><span class="ref-journal">Biochem Biophys Res Commun. </span>2012;<span class="ref-vol">420</span>(4):787–792. doi: 10.1016/j.bbrc.2012.03.075.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/22459450" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1016%2Fj.bbrc.2012.03.075" target="pmc_ext" ref="reftype=other&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR19">19. <span class="element-citation">Yu F, Cui Y, Zhou X, Zhang X, Han J. Osteogenic differentiation of human ligament fibroblasts induced by conditioned medium of osteoclast-like cells. <span><span class="ref-journal">Biosci Trends. </span>2011;<span class="ref-vol">5</span>(2):46–51. doi: 10.5582/bst.2011.v5.2.46.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/21572246" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.5582%2Fbst.2011.v5.2.46" target="pmc_ext" ref="reftype=other&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR20">20. <span class="element-citation">Hamam D, Ali D, Vishnubalaji R, Hamam R, Al-Nbaheen M, Chen L, et al.  microRNA-320/RUNX2 axis regulates adipocytic differentiation of human mesenchymal (skeletal) stem cells. <span><span class="ref-journal">Cell Death Dis. </span>2014;<span class="ref-vol">5</span>:e1499. doi: 10.1038/cddis.2014.462.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC4237271/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/25356868" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1038%2Fcddis.2014.462" target="pmc_ext" ref="reftype=other&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR21">21. <span class="element-citation">Patterson EE, Holloway AK, Weng J, Fojo T, Kebebew E. MicroRNA profiling of adrenocortical tumors reveals miR-483 as a marker of malignancy. <span><span class="ref-journal">Cancer. </span>2011;<span class="ref-vol">117</span>(8):1630–1639. doi: 10.1002/cncr.25724.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC3051015/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/21472710" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1002%2Fcncr.25724" target="pmc_ext" ref="reftype=other&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR22">22. <span class="element-citation">Yu X, Zhang X, Bi T, Ding Y, Zhao J, Wang C, et al.  MiRNA expression signature for potentially predicting the prognosis of ovarian serous carcinoma. <span><span class="ref-journal">Tumour Biol. </span>2013;<span class="ref-vol">34</span>(6):3501–3508. doi: 10.1007/s13277-013-0928-3.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/23836287" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1007%2Fs13277-013-0928-3" target="pmc_ext" ref="reftype=other&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR23">23. <span class="element-citation">Zuntini M, Salvatore M, Pedrini E, Parra A, Sgariglia F, Magrelli A, et al.  MicroRNA profiling of multiple osteochondromas: identification of disease-specific and normal cartilage signatures. <span><span class="ref-journal">Clin Genet. </span>2010;<span class="ref-vol">78</span>(6):507–516. doi: 10.1111/j.1399-0004.2010.01490.x.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/20662852" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1111%2Fj.1399-0004.2010.01490.x" target="pmc_ext" ref="reftype=other&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR24">24. <span class="element-citation">Diaz-Prado S, Cicione C, Muinos-Lopez E, Hermida-Gomez T, Oreiro N, Fernandez-Lopez C, et al.  Characterization of microRNA expression profiles in normal and osteoarthritic human chondrocytes. <span><span class="ref-journal">BMC Musculoskelet Disord. </span>2012;<span class="ref-vol">13</span>:144. doi: 10.1186/1471-2474-13-144.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC3495209/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/22883423" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1186%2F1471-2474-13-144" target="pmc_ext" ref="reftype=other&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR25">25. <span class="element-citation">Dai N, Zhong ZY, Cun YP, Qing Y, Chen C, Jiang P, et al.  Alteration of the microRNA expression profile in human osteosarcoma cells transfected with APE1 siRNA. <span><span class="ref-journal">Neoplasma. </span>2013;<span class="ref-vol">60</span>(4):384–394. doi: 10.4149/neo_2013_050.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/23581410" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.4149%2Fneo_2013_050" target="pmc_ext" ref="reftype=other&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR26">26. <span class="element-citation">Liu M, Roth A, Yu M, Morris R, Bersani F, Rivera MN, et al.  The IGF2 intronic miR-483 selectively enhances transcription from IGF2 fetal promoters and enhances tumorigenesis. <span><span class="ref-journal">Genes Dev. </span>2013;<span class="ref-vol">27</span>(23):2543–2548. doi: 10.1101/gad.224170.113.</span> <span class="nowrap ref pmc">[<a class="int-reflink" href="/pmc/articles/PMC3861668/">PMC free article</a>]</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/24298054" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1101%2Fgad.224170.113" target="pmc_ext" ref="reftype=other&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR27">27. <span class="element-citation">Ma N, Wang X, Qiao Y, Li F, Hui Y, Zou C, et al.  Coexpression of an intronic microRNA and its host gene reveals a potential role for miR-483-5p as an IGF2 partner. <span><span class="ref-journal">Mol Cell Endocrinol. </span>2011;<span class="ref-vol">333</span>(1):96–101. doi: 10.1016/j.mce.2010.11.027.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/21146586" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1016%2Fj.mce.2010.11.027" target="pmc_ext" ref="reftype=other&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR28">28. <span class="element-citation">Qi Y, Ma N, Yan F, Yu Z, Wu G, Qiao Y, et al.  The expression of intronic miRNAs, miR-483 and miR-483*, and their host gene, Igf2, in murine osteoarthritis cartilage. <span><span class="ref-journal">Int J Biol Macromol. </span>2013;<span class="ref-vol">61</span>:43–49. doi: 10.1016/j.ijbiomac.2013.06.006.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/23791756" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1016%2Fj.ijbiomac.2013.06.006" target="pmc_ext" ref="reftype=other&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR29">29. <span class="element-citation">Minuto F, Palermo C, Arvigo M, Barreca AM. The IGF system and bone. <span><span class="ref-journal">J Endocrinol Invest. </span>2005;<span class="ref-vol">28</span>(8 Suppl):8–10.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/16323822" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR30">30. <span class="element-citation">Baron R, Kneissel M. WNT signaling in bone homeostasis and disease: from human mutations to treatments. <span><span class="ref-journal">Nat Med. </span>2013;<span class="ref-vol">19</span>(2):179–192. doi: 10.1038/nm.3074.</span>  <span class="nowrap ref pubmed">[<a href="/pubmed/23389618" target="pmc_ext" ref="reftype=pubmed&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord&amp;rendering-type=normal">PubMed</a>]</span> <span class="nowrap ref crossref">[<a href="//dx.doi.org/10.1038%2Fnm.3074" target="pmc_ext" ref="reftype=other&amp;article-id=4640351&amp;issue-id=248132&amp;journal-id=573&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI&amp;rendering-type=normal">Cross Ref</a>]</span></span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr />Articles from <span class="acknowledgment-journal-title">BMC Medical Genomics</span> are provided here courtesy of <strong>BioMed Central</strong></div></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC4640351/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC4640351/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC4640351/pdf/12920_2015_Article_149.pdf">PDF (964K)</a></li> | <li><a href="#" data-citationid="PMC4640351" class="citationexporter ctxp">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4640351%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook" />
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4640351%2F&amp;text=MiRNA%20profiling%20of%20whole%20trabecular%20bone%3A%20identification%20of%20osteoporosis-related%20changes%20in%20MiRNAs%20in%20human%20hip%20bones"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter" />
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4640351%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus" />
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="26555194" data-aiid="4640351" data-aid="4640351" data-iid="248132" data-domainid="573" data-domain="bmcmedgeno" data-accid="PMC4640351" data-md5="93d75be4b4d235c77bc1076dc5a5077c"></div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"></div>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2018-07-16T19:05:45-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=ptpmc202&amp;ncbi_phid=F4FC6075B4D23A2100000000008E006F&amp;ncbi_session=F4FC6075B4D24C81_0142SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4640351%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=bmcmedgeno&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC4640351/&amp;ncbi_app=pmc" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- F4FC6075B4D24C81_0142SID /projects/PMC/PMCViewer@4.46 ptpmc202 v4.1.r563004 Tue, May 01 2018 03:01:28 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script></body>
</html>